Angiotensin II Induces Inflammatory Response Partly Via Toll-Like Receptor 4-Dependent Signaling Pathway in Vascular Smooth Muscle Cells

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cellular Physiology and Biochemistry

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1159/000218173PMID 19471094
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells.

  2008cited by this paper
• NF-κB as an integrator of diverse signaling pathways

  2007cited by this paper
• Angiotensin II-induced C-reactive protein generation: inflammatory role of vascular smooth muscle cells in atherosclerosis.

  2007cited by this paper
• Endotoxin Induces Toll-Like Receptor 4 Expression in Vascular Smooth Muscle Cells via NADPH Oxidase Activation and Mitogen-Activated Protein Kinase Signaling Pathways

  2006cited by this paper
• DUSP Meet Immunology: Dual Specificity MAPK Phosphatases in Control of the Inflammatory Response1

  2006cited by this paper
• MMP-9 Microsatellite Polymorphism and Susceptibility to Carotid Arteries Atherosclerosis

  2006cited by this paper
• Atherosclerosis: humoral and cellular factors of inflammation

  2005cited by this paper
• A New Cellular Signaling Mechanism for Angiotensin II Activation of NF-&kgr;B: An I&kgr;B–Independent, RSK–Mediated Phosphorylation of p65

  2005cited by this paper
• Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques.

  2005cited by this paper
• Angiotensin II induces tyrosine nitration and activation of ERK1/2 in vascular smooth muscle cells

  2005cited by this paper
• Angiotensin II and vascular inflammation.

  2005cited by this paper
• Toll-like receptor signalling

  2004cited by this paper
• Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation.

  2004cited by this paper
• Regulation of Endotoxin-Induced Proinflammatory Activation in Human Coronary Artery Cells: Expression of Functional Membrane-Bound CD14 by Human Coronary Artery Smooth Muscle Cells1

  2004cited by this paper
• Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.

  2004cited by this paper
• Toll-like Receptor Signaling*

  2003cited by this paper
• Recognition of pathogen-associated molecular patterns by TLR family.

  2003cited by this paper
• Toll-Like Receptor Signaling Pathways

  2003cited by this paper
• PKCε is a permissive link in integrin-dependent IFN-γ signalling that facilitates JAK phosphorylation of STAT1

  2003cited by this paper
• PKCepsilon is a permissive link in integrin-dependent IFN-gamma signalling that facilitates JAK phosphorylation of STAT1.

  2003cited by this paper
• NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling?

  2003cited by this paper
• Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome.

  2003cited by this paper
• Emerging roles of PPARS in inflammation and immunity

  2002cited by this paper
• Innate immune recognition.

  2002cited by this paper
• Critical role of protein kinase C ϵ for lipopolysaccharide‐induced IL‐12 synthesis in monocyte‐derived dendritic cells

  2002cited by this paper
• Inflammation in atherosclerosis

  2002cited by this paper
• Toll-like receptor 4 polymorphisms and atherogenesis.

  2002cited by this paper
• Toll-like receptor 4 polymorphisms and atherogenesis.

  2002cited by this paper
• The role of PPARs in atherosclerosis.

  2002cited by this paper
• Expression of Toll-Like Receptors in Human Atherosclerotic Lesions: A Possible Pathway for Plaque Activation

  2002cited by this paper
• Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL

  2001cited by this paper
• Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells*

  2001cited by this paper
• Protein Kinase C ζ Phosphorylates a Subset of Selective Sites of the NADPH Oxidase Component p47phox and Participates in Formyl Peptide-Mediated Neutrophil Respiratory Burst

  2001cited by this paper
• PKCε modulates NF-κB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes

  2000cited by this paper
• Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation

  2000cited by this paper
• Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells.

  2000cited by this paper
• Bacterial Lipopolysaccharide Activates NF-κB through Toll-like Receptor 4 (TLR-4) in Cultured Human Dermal Endothelial Cells

  2000cited by this paper
• PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes.

  2000cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Angiotensin induces inflammatory activation of human vascular smooth muscle cells.

  1999cited by this paper
• Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis.

  1999cited by this paper
• Tolerance development to antimitogenic actions of prostacyclin but not of prostaglandin E1 in coronary artery smooth muscle cells.

  1998cited by this paper
• Characterization of phosphatidylinositol-specific phospholipase C from cultured vascular smooth muscle cells.

  1991cited by this paper
• Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells.

  1989cited by this paper

• NLR/inflammasome pathway in cardiovascular disorders: from pathogenesis to potential therapies

  2025cites this paper
• Imperatorin's Effect on Myocardial Infarction Based on Network Pharmacology and Molecular Docking

  2025cites this paper
• 10-Hydroxydec-2-enoic acid reduces vascular smooth muscle cell inflammation via interacting with Toll-like receptor 4.

  2025cites this paper
• Schisandrin B alleviates angiotensin II-induced cardiac inflammatory remodeling by inhibiting the recruitment of MyD88 to TLRs in mouse cardiomyocytes.

  2024cites this paper
• The Complex Connection Between Myocardial Dysfunction and Cancer Beyond Cardiotoxicity: Shared Risk Factors and Common Molecular Pathways

  2024cites this paper
• Current Mouse Models of Intracranial Aneurysms: Analysis of Pharmacological Agents Used to Induce Aneurysms and Their Impact on Translational Research.

  2024cites this paper
• Pharmacological Mechanisms of Cryptotanshinone: Recent Advances in Cardiovascular, Cancer, and Neurological Disease Applications

  2024cites this paper
• New insights into the long non-coding RNAs dependent modulation of heart failure and cardiac hypertrophy: From molecular function to diagnosis and treatment.

  2023cites this paper
• Immunomodulation and immunopharmacology in heart failure

  2023cites this paper
• Sanguinarine-Chelerythrine Fraction of Coptis chinensis Exerts Anti-inflammatory Activity in Carrageenan Paw Oedema Test in Rats and Reveals Reduced Gastrotoxicity

  2022cites this paper
• Sodium chloride-induced changes in oxidative stress, inflammation, and dysbiosis in experimental multiple sclerosis

  2022cites this paper
• The COVID-19-diabetes mellitus molecular tetrahedron

  2022cites this paper
• Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities

  2022cites this paper
• Prospective Role of Bioactive Molecules and Exosomes in the Therapeutic Potential of Camel Milk against Human Diseases: An Updated Perspective

  2022cites this paper
• Oxidized low-density lipoprotein induced hepatoma-derived growth factor upregulation mediates foam cell formation of cultured rat aortic vascular smooth muscle cells.

  2021cites this paper
• Renal Inflammation and Innate Immune Activation Underlie the Transition From Gentamicin-Induced Acute Kidney Injury to Renal Fibrosis

  2021cites this paper
• Valsartan Prevented Neointimal Hyperplasia and Inhibited SRSF1 Expression and the TLR4-iNOS-ERK-AT1 Receptor Pathway in the Balloon-injured Rat Aorta.

  2021cites this paper
• Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges

  2021cites this paper
• Renin-Angiotensin System Induced Secondary Hypertension: The Alteration of Kidney Function and Structure

  2021cites this paper
• Brain Angiotensin Type-1 and Type-2 Receptors in Physiological and Hypertensive Conditions: Focus on Neuroinflammation

  2020cites this paper
• The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease.

  2020cites this paper
• Nerolidol improves cardiac function in spontaneously hypertensive rats by inhibiting Cardiac Inflammation and remodelling associated TLR4/ NF-κB signalling cascade.

  2020cites this paper
• Sympathetic Activation in Hypertension: Importance of the Central Nervous System.

  2020cites this paper
• The role of Immunity in Fabry Disease and Hypertension: A Review of a Novel Common Pathway

  2020cites this paper
• Pattern recognition receptor‐mediated inflammation in diabetic vascular complications

  2020cites this paper
• Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications

  2020cites this paper
• Phosphatidylglycerol and surfactant: A potential treatment for COVID-19?

  2020influential citation
• Overexpression of microRNA-21 mediates Ang II-induced renal fibrosis by activating the TGF-β1/Smad3 pathway via suppressing PPARα.

  2019cites this paper
• Osthole protects against Ang II-induced endotheliocyte death by targeting NF-κB pathway and Keap-1/Nrf2 pathway.

  2019cites this paper
• Pathogenic role of innate immunity in a model of chronic NO inhibition associated with salt overload.

  2019cites this paper
• Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors.

  2019cites this paper
• Inflammation, Immunity, and Oxidative Stress in Hypertension-Partners in Crime?

  2019cites this paper
• Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer.

  2019cites this paper
• Role of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in airway reactivity and inflammation in an allergic mouse model of asthma

  2019cites this paper
• Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells

  2018cites this paper
• Klotho Inhibits Proliferation and Migration of Angiotensin II-Induced Vascular Smooth Muscle Cells (VSMCs) by Modulating NF-κB p65, Akt, and Extracellular Signal Regulated Kinase (ERK) Signaling Activities

  2018cites this paper
• Inhibition of angiotensin II receptor I prevents inflammation and bone loss in periodontitis

  2018cites this paper
• Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance

  2018cites this paper
• Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular Matrix Remodeling

  2018cites this paper
• Protein Arginine Methyltransferase 2 Inhibits Angiotensin II-Induced Proliferation and Inflammation in Vascular Smooth Muscle Cells

  2018cites this paper
• EET Intervention on HO-1 Prevent Obesity Derived Cardiovascular Diseases

  2018cites this paper
• Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll‐like receptor 4

  2018cites this paper
• Angiotensin II Causes Biphasic STAT3 Activation Through TLR4 to Initiate Cardiac Remodeling

  2018cites this paper
• Paeoniflorin inhibits VSMCs proliferation and migration by arresting cell cycle and activating HO‐1 through MAPKs and NF‐&kgr;B pathway

  2018cites this paper
• LncRNA myocardial infarction‐associated transcript (MIAT) contributed to cardiac hypertrophy by regulating TLR4 via miR‐93

  2018cites this paper
• Regulation of angiotensin II-induced B-cell lymphoma-2-associated athanogene 3 expression in vascular smooth muscle cells.

  2018cites this paper
• Role of Toll-like receptors and interferon regulatory factors in different experimental heart failure models of diverse etiology: IRF7 as novel cardiovascular stress-inducible factor

  2018cites this paper
• Correlations between gene expression highlight a different activation of ACE/TLR4/PTGS2 signaling in symptomatic and asymptomatic plaques in atherosclerotic patients

  2018cites this paper
• Targeting toll‐like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension?

  2018cites this paper
• Toll‐like receptor 4 (TLR4) impairs nitric oxide contributing to Angiotensin II‐induced cavernosal dysfunction

  2017cites this paper
• Desarrollo de tecnologías proteómicas de última generación aplicadas al estudio del remodelado vascular

  2017cites this paper
• Lipopolysaccharide induced vascular smooth muscle cells proliferation: A new potential therapeutic target for proliferative vascular diseases

  2017cites this paper
• Lipopolysaccharides, but not Angiotensin ll, lnduces Direct Pro‐lnflammatory Effects in Cultured Mouse Arteries and Human Endothelial and Vascular Smooth Muscle Cells

  2017cites this paper
• Role of Oxidative Stress and Associated Alteration in Enzyme Activities in Obesity Comorbidities

  2017cites this paper
• Are the innate and adaptive immune systems setting hypertension on fire?

  2017influential citation
• High mobility group box 1 induces calcification of aortic valve interstitial cells via toll-like receptor 4

  2017cites this paper
• miR-19a and miR-20a and Tissue Factor Expression in Activated Human Peripheral Blood Mononuclear Cells

  2017cites this paper
• The interplay between Angiotensin II, TLR4 and hypertension.

  2017cites this paper
• Redox regulation of cardiovascular inflammation – Immunomodulatory function of mitochondrial and Nox‐derived reactive oxygen and nitrogen species

  2017cites this paper
• Interleukin 17A and Toll-like Receptor 4 in Patients with Arterial Hypertension

  2017cites this paper
• LPS Promotes Vascular Smooth Muscle Cells Proliferation Through the TLR4/Rac1/Akt Signalling Pathway

  2017cites this paper
• Angiotensin Mediated Oxidative Stress and Neuroprotective Potential of Antioxidants and AT1 Receptor Blockers.

  2017cites this paper
• Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.

  2017cites this paper
• Role of the Immune System in Hypertension.

  2017cites this paper
• Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2)

  2017cites this paper
• Interleukin 17 A and Toll-like Receptor 4 in Patients with Arterial Hypertension

  2017cites this paper
• Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice

  2016cites this paper
• Obese Patient-Derived Sera have Proinflammatory Effect

  2016cites this paper
• The effect of high glucose on the inhibitory action of C21, a selective AT2R agonist, of LPS-stimulated tissue factor expression in human mononuclear cells

  2016cites this paper
• Toll-like receptors mediating vascular malfunction: Lessons from receptor subtypes.

  2016cites this paper
• TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension.

  2016cites this paper
• Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders.

  2016cites this paper
• MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway

  2016cites this paper
• Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus.

  2016cites this paper
• Cross talk between AT 1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus

  2016cites this paper
• TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase

  2015cites this paper
• Toll‐like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II‐induced hypertension

  2015cites this paper
• Cross-talk between angiotensin-II and toll-like receptor 4 triggers a synergetic inflammatory response in rat mesangial cells under high glucose conditions.

  2015cites this paper
• Circulating Toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade.

  2015cites this paper
• Obesity and insulin resistance in resistant hypertension: implications for the kidney.

  2015cites this paper
• Obese Patient-Derived Sera Have Proinflammatory Effect

  2015cites this paper
• Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension

  2015cites this paper
• The immune system and hypertension

  2014cites this paper
• Toll-Like Receptor 4 Upregulation by Angiotensin II Contributes to Hypertension and Vascular Dysfunction through Reactive Oxygen Species Production

  2014cites this paper
• Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.

  2014cites this paper
• A role for innate immunity in the development of hypertension.

  2014cites this paper
• Toll-Like Receptor 4 Mediates Inflammatory Cytokine Secretion in Smooth Muscle Cells Induced by Oxidized Low-Density Lipoprotein

  2014cites this paper
• The immunological basis of hypertension.

  2014cites this paper
• The Angiotensin II Type 1 Receptor (AT1R) Closely Interacts with Large Conductance Voltage- and Ca2+-activated K+ (BK) Channels and Inhibits Their Activity Independent of G-protein Activation*

  2014cites this paper
• Toll-like receptors and hypertension.

  2014cites this paper
• Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production

  2014cites this paper
• Compound 21, a selective angiotensin II type 2 receptor agonist, downregulates lipopolysaccharide-stimulated tissue factor expression in human peripheral blood mononuclear cells

  2014cites this paper
• Role of Toll-like receptors in diabetic nephropathy.

  2014cites this paper
• Diuresis Toll-like receptors and hypertension

  2014cites this paper
• Biological role of Toll-like receptor-4 in the brain.

  2014cites this paper
• Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques.

  2014cites this paper
• WITHDRAWN: Angiotensin II-induced endogenous cholesterol synthesis in human monocytes of patients with dyslipidemia

  2014cites this paper
• Mechanisms of vascular disease: divergent roles for suppressor of cytokine signaling 3 in angiotensin II-induced vascular dysfunction

  2014cites this paper
• Title: The Toll-like Receptors and Hypertension

  2014cites this paper
• Angiotensin Converting Enzyme Insertion/Deletion (ACE I/D) and Methylene Tetrahydrofolate Reductase C677T (MTHFR C677T) genetic polymorphisms in the pathogenesis of abdominal aortic aneurysms (AAA)

  2013cites this paper